Best deal of the week
DR. DOPING

Instructions

Logo DR. DOPING

Instruction for use: Flucinar N

I want this, give me price

Active substance Neomycin + Fluocinolone acetonide

ATX code D07CC02 Fluorocinolone acetonide in combination with antibiotics

Pharmacological group

Glucocorticosteroids in combinations

Nosological classification (ICD-10)

L00-L08 Infections of the skin and subcutaneous tissue

L02 Skin abscess, furuncle and carbuncle

Furuncle of external auditory canal, Furuncle of the auricle, Furuncles, Abscess, Abscess of skin, Carbuncle, Carbuncle skin, Furuncle, Skin furuncle, Furunculosis, Chronic recurrent furunculosis

L20 Atopic dermatitis

Itchy atopic eczema, Common neurodermatitis, Allergic skin diseases, Allergic skin diseases of non-infectious etiology, Allergic skin diseases of non-microbial etiology, Allergic skin diseases, Allergic skin lesions, Allergic manifestations on the skin, Allergic dermatitis, Allergic diathesis, Allergic itching dermatosis, Allergic Skin Disease, Allergic skin irritation, Dermatitis allergic, Atopic dermatitis, Dermatosis allergic, Diathesis exudative, Skin Allergic Disease, Skin allergic reaction to medicinal and chemical preparations, Skin reaction to medication, Skin and allergic disease, Acute eczema, Chronic atopic dermatitis, Exudative diathesis, Itching allergic dermatosis

L73.2 Hyperadenitis purulent

Hydradenite, Bony udders

L73.8.0 * Sycosis

Sycosis of the beard

L73.8.1 * Folliculitis

Superficial folliculitis, Folliculitis

L87 Transepidermal perforations

Composition and form of release

Ointment 1 g

Fluocinolone acetonide 0.25 mg

Neomycin sulfate 5 mg

Auxiliary substances: propylene glycol; Paraffin liquid; Lanolin anhydrous; Petroleum jelly white

In tubes of 15 g; In a pack of cardboard 1 tuba.

pharmachologic effect

Pharmacological action - anti-inflammatory, antibacterial, antiallergic, antipruritic.

Oppresses phospholipase A2, reduces the synthesis of PG (prostaglandins) and other biologically active substances (fluocinolone); Breaks the structure and function of cytoplasmic membranes of microbial cells and causes their death (neomycin).

Pharmacodynamics

Reduces permeability and changes the structure of tissue and cell formations, reduces the migration of macrophages and lymphocytes, affects all phases of inflammation, blocks the release of sensitized mast cells and basophils of histamine and other biologically active substances, has anti-allergic and antipruritic effect. It is active against numerous gram-positive and gram-negative microorganisms, incl. Resistant to other aminoglycosides.

Indications

Allergic and inflammatory skin diseases complicated by a secondary bacterial infection, trophic ulcers of the shins, furunculosis, folliculitis.

Contraindications

Hypersensitivity, tuberculosis, viral and fungal skin infections, primary purulent infections of the skin and soft tissues.

pregnancy and lactation

Not recommended (especially on large areas of the skin and / or prolonged use).

Side effects

Skin and subcutaneous fat atrophy, lupus-like syndrome with mild course, appearance or exacerbation of symptoms of red flat lichen, epithelialization disorders, slow healing of wounds and ulcerative lesions, petechiae, steroid purpura, striae, hirsutism, female alopecia, herpes, maculopapular skin rash.

Dosing and Administration

Externally, a small amount is applied to the affected skin 2-3 times a day, no more than 2 g / day, after remission of the acute inflammatory process - 1-2 times a day. If necessary, apply a breathable bandage. With excessive peeling of the stratum corneum of the epidermis (lichenization) or excessive keratinization of the altered areas, an occlusive dressing can be used, which is changed every 24-48 hours. The course of continuous treatment is no more than 2 weeks.

Children older than 2 years with caution, only once a day on small areas of the skin.

It should not be used during pregnancy, during breastfeeding, in children under 2 years.

Precautionary measures

For prolonged use and when applied to large areas of the skin (under occlusive dressings), patients should undergo systematic examinations (systemic side effects may occur).

Storage conditions

At a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiry date printed on the package.

Someone from the United Kingdom - just purchased the goods:
Cerebrolysat injection 5ml 10 vials